Nip+Fab introduces new premium range with full ingredient, testing and cost transparency

Nip+Fab has launched The Fix, a three-product skincare system aimed at consumers aged 30 and over, combining active-led formulations with a commitment to disclose ingredient levels, testing reports and the costs behind its pricing.

The range has been developed around visible signs commonly associated with skin ageing, including fine lines, loss of firmness, dehydration and barrier concerns, uneven skin tone and photoageing. Nip+Fab says these concerns informed the selection and distribution of actives across the three products.

The choice of ingredients and their concentrations was guided by published evidence. Key actives include Niacinamide PC, which Nip+Fab has selected in place of conventional niacinamide, and CycloRetin, a peptide derived from Prince Ginseng that the brand positions as a retinol alternative.

The Fix comprises a serum, cream and UVA Day Shield. According to Nip+Fab, the serum is formulated to provide an immediate lifting effect while supporting longer-term collagen synthesis. The cream focuses on cellular energy and combines a peptide with an NAD+ booster, while the UVA Day Shield is designed for daytime use to help protect skin from UV exposure.

The products can be used individually, although Nip+Fab has developed them as a three-step routine. The serum and cream are priced at £69.95 each, while the UVA Day Shield costs £59.95. All three products are 50ml, bringing the complete routine to £199.85.

The launch follows feedback from consumers who wanted results without a lengthy routine but remained sceptical of skincare claims. “They just wanted to feel like someone told the truth,” Managing Director Michael Hume tells TheIndustry.beauty.

Transparency is a central part of the launch. Nip+Fab says it will publish the inclusion level of each ingredient, alongside the reasoning for its use, rather than relying solely on an INCI list, which does not disclose exact quantities.

The company also plans to publish full testing reports, including clinical studies, laboratory results and raw data supplied by ingredient manufacturers. The information will be available alongside the formulation details and supporting evidence on The Fix website.

There is one exception to the ingredient-level disclosure. The UVA Day Shield contains a seven-filter UV system that accounts for 23% of the formula, but Nip+Fab says the individual percentages of those filters will remain confidential at the request of its manufacturing partner. The company will, however, disclose the filters used and publish the product’s protection testing.

Nip+Fab also notes that it will disclose the costs behind the products’ retail prices, including the formula, bottle, carton, shipping, staff and testing.

The company says development of The Fix took two years and 17 days from the initial brief to launch, with the full development record published as part of its transparency programme.

“This is not simply another product launch, it is a movement, the setting of new industry benchmarks in transparency, just as we did 15 years ago. Skincare has become noise and misinformation, and we wanted to remove it rather than add to it. We wanted to re-establish trust with people who are rightly sceptical of topical skincare,” explains Hume.

“That meant publishing everything: every ingredient at the level we use it, every test we ran, including the ones we did not pass first time and what it costs us to make it. Not just creating the most efficacious system for preventing and reversing the hallmarks of ageing out there, at any price point. Creating trust. Then giving it to people qualified to find the flaws, unpaid, with no ability for us to stop them saying whatever they conclude.”

As part of the launch, Nip+Fab approached around 200 independent experts, including cosmetic scientists, formulators, safety assessors and dermatologists. Those who chose to participate did so without payment and are free to publish their conclusions through their own channels, without the brand reviewing or approving their findings.

The company has also filmed its formulators discussing the development process, including some of the challenges encountered along the way. Nip+Fab says it hopes this combination of independent scrutiny and greater visibility into the development process will encourage more transparency across the wider skincare industry.

Hume added that Nip+Fab would not use paid influencer collaborations to promote The Fix, although the company does use paid collaborations elsewhere across its business.

The Fix will initially launch direct-to-consumer. Hume said DTC sales now account for 43% of Nip+Fab’s business, which he said has doubled in size over the past six years.

Nip+Fab said the direct-to-consumer model will allow it to sell the three-product system at its stated prices while publishing the costs behind them.

Retail distribution could follow, although no stockists have been confirmed. Hume said the company had declined distribution offers on the terms proposed: “We’ve been offered distribution already, but we’ve had to turn it down because it’s not commercially viable to do so.”